BIT 0.00% 5.0¢ biotron limited

$10 Billion Deal, page-141

  1. 16,253 Posts.
    lightbulb Created with Sketch. 742
    "Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial "

    Can someone explain how they came to this conclusion in a short time frame after treatment based on 27 patients with half on placebo. The variability of data on such a small patient population looking at immune system ages and neurocognitive disorder is going to give you non conclusive data imo. Longer term data on over 300 patients in a phase 2b study can only give any significant results. IMO the reported results are a beat up to get the 6c options exercised.


    "These include an immune system ages more quickly, and there are other problems such as HIV-associated neurocognitive disorder (also known as AIDS-related dementia).
    Last edited by malmanu: 13/11/18
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
5.0¢
Change
0.000(0.00%)
Mkt cap ! $45.11M
Open High Low Value Volume
4.9¢ 5.0¢ 4.9¢ $11.17K 227.7K

Buyers (Bids)

No. Vol. Price($)
2 58063 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 109027 4
View Market Depth
Last trade - 12.35pm 17/06/2024 (20 minute delay) ?
Last
5.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
4.9¢ 5.0¢ 4.9¢ 61814
Last updated 13.21pm 17/06/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.